Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
The establishment, analysis and presentation of data from biologics registers in rheumatology |
| Full bibliographic reference | Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R, Listing J, Nicola PJ, Tarp U, Zink A, Askling J. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis. 2010;69(9):1596-1602. |
| Language | English |
| PubMed ID | 20525843 |
| Study design | Observational studies |
| Clinical area | Rheumatology |
| Applies to the whole report or to individual sections of the report? | Whole report |
| Record last updated on | January 27, 2015 |